Replies to post #12751 on GeneSYS ID Inc fka GNID

[DCorleone]

And yet, you are basing your RXSF investment here on PR Releases and 150 million dollar Projections. My point is, CEO should treat both sides of the "NEWS" equally. If she has time to do projections on sales, give the potential unauthorized "EARLY" share release story, equal billing. The key word is EARLY.
Float was posted at 325k+
OS was posted at 1,510,252
As for the CEO Seat, NO THANK YOU! The CEO is important, but ultimately it will be the the merits of the RXSF product that determines success or failure.
CEO's come and go as IHUB posters...